Morphine-6-glucuronide induces contraction of the ileal circular muscle more potently than morphine in mice

European Journal of Pharmacology

Volumn 600, Issue 1-3, 2008, Pages 130-132

  Iwata, Hiroki ^a   Tsuchiya, Shizuko ^a   Ueno, Koichi ^a   Nakamura, Tomonori ^a   Yano, Shingo ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Circular muscle contraction; Morphine; Morphine 3 glucuronide; Morphine 6 glucuronide; Mouse ileum

Indexed keywords

MORPHINE; MORPHINE 3 GLUCURONIDE; MORPHINE 6 GLUCURONIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; ILEUM; INTESTINE CONTRACTION; INTESTINE MUSCLE; INTESTINE TRANSIT TIME; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; GASTROINTESTINAL TRANSIT; ILEUM; MALE; MICE; MORPHINE; MORPHINE DERIVATIVES; MUSCLE CONTRACTION;

EID: 55949093717     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.10.009     Document Type: Article

References (15)

1. Frances B., Gout R., Monsarrat B., Cros J., and Zajac J.M. Further evidence that morphine-6β-glucuronide is a more potent opioid agonist than morphine. J. Pharmacol. Exp. Ther. 262 (1992) 25-31
2. Gong Q.L., Hedner J., Bjorkman R., and Hedner T. Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat. Pain 48 (1992) 249-255
3. Hasselstrom J., and Sawe J. Morphine pharmacokinetics and metabolism in humans. enterohepatic cycling and relative contribution of metabolites to active opioid concentrations. Clin. Pharmacokinet. 24 (1993) 344-354
4. Ivancheva C., and Radomirov R. Control of non-adrenergic non-cholinergic reflex motor responses in circular muscle of guinea-pig small intestine by Met-enkephalin. Auton. Autacoid Pharmacol. 22 (2002) 199-207
5. Iwata H., Tsuchiya S., Nakamura T., and Yano S. Morphine leads to contraction of the ileal circular muscle via inhibition of the nitrergic pathway in mice. Eur. J. Pharmacol. 574 (2007) 66-70
6. King M.A., Su W., Nielan C.L., Chang A.H., Schutz J., Schmidhammer H., and Pasternak G.W. 14-Methoxymetopon, a very potent μ-opioid receptor-selective analgesic with an unusual pharmacological profile. Eur. J. Pharmacol. 459 (2003) 203-209
7. Massi P., Giagnoni G., Basilico L., Gori E., Rubino T., and Parolaro D. Intestinal effect of morphine 6-glucuronide: in vivo and in vitro characterization. Eur. J. Pharmacol. 253 (1994) 269-274
8. Mignat C., Wille U., and Ziegler A. Affinity profiles of morphine, codeine, dihydrocodeine and their glucuronides at opioid receptor subtypes. Life Sci. 56 (1995) 793-799
9. Osborne R., Joel S., Trew D., and Slevin M. Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide. Clin. Pharmacol. Ther. 47 (1990) 12-19
10. Pasternak G.W. Incomplete cross tolerance and multiple mu opioid peptide receptors. Trends Pharmacol. Sci. 22 (2001) 67-70
11. Pasternak G.W., Bodnar R.J., Clark J.A., and Inturrisi C.E. Morphine-6-glucuronide, a potent mu agonist. Life Sci. 41 (1987) 2845-2849
12. Paul D., Standifer K.M., Inturrisi C.E., and Pasternak G.W. Pharmacological characterization of morphine-6β-glucuronide, a very potent morphine metabolite. J. Pharmacol. Exp. Ther. 251 (1989) 477-483
13. Romberg R., Sarton E., Teppema L., Matthes H.W., Kieffer B.L., and Dahan A. Comparison of morphine-6-glucuronide and morphine on respiratory depressant and antinociceptive responses in wild type and μ-opioid receptor deficient mice. Br. J. Anaesth. 91 (2003) 862-870
14. Schmidt N., Brune K., and Geisslinger G. Opioid receptor agonist potencies of morphine and morphine-6-glucuronide in the guinea-pig ileum. Eur. J. Pharmacol. 255 (1994) 245-247
15. Shimomura K., Kamata O., Ueki S., Ida S., and Oguri K. Analgesic effect of morphine glucuronides. Tohoku J. Exp. Med. 105 (1971) 45-52